249 related articles for article (PubMed ID: 23263697)
21. Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.
McDonald BC; Conroy SK; Smith DJ; West JD; Saykin AJ
Brain Behav Immun; 2013 Mar; 30 Suppl(0):S117-25. PubMed ID: 22613170
[TBL] [Abstract][Full Text] [Related]
22. Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?
Billiet T; Emsell L; Vandenbulcke M; Peeters R; Christiaens D; Leemans A; Van Hecke W; Smeets A; Amant F; Sunaert S; Deprez S
Brain Imaging Behav; 2018 Feb; 12(1):64-77. PubMed ID: 28102529
[TBL] [Abstract][Full Text] [Related]
23. Functional brain imaging in survivors of critical illness: A prospective feasibility study and exploration of the association between delirium and brain activation patterns.
Jackson JC; Morandi A; Girard TD; Merkle K; Graves AJ; Thompson JL; Shintani AK; Gunther ML; Cannistraci CJ; Rogers BP; Gore JC; Warrington HJ; Ely EW; Hopkins RO;
J Crit Care; 2015 Jun; 30(3):653.e1-7. PubMed ID: 25769901
[TBL] [Abstract][Full Text] [Related]
24. Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy.
Ferguson RJ; McDonald BC; Saykin AJ; Ahles TA
J Clin Oncol; 2007 Sep; 25(25):3866-70. PubMed ID: 17761972
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints.
Deprez S; Vandenbulcke M; Peeters R; Emsell L; Smeets A; Christiaens MR; Amant F; Sunaert S
J Clin Oncol; 2014 Jul; 32(19):2031-8. PubMed ID: 24868029
[TBL] [Abstract][Full Text] [Related]
26. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy.
Inagaki M; Yoshikawa E; Matsuoka Y; Sugawara Y; Nakano T; Akechi T; Wada N; Imoto S; Murakami K; Uchitomi Y
Cancer; 2007 Jan; 109(1):146-56. PubMed ID: 17131349
[TBL] [Abstract][Full Text] [Related]
27. Prospective evaluation of functional brain activity and oxidative damage in breast cancer: changes in task-induced deactivation during a working memory task.
Root JC; Pergolizzi D; Pan H; Orlow I; Passik SD; Silbersweig D; Stern E; Ahles TA
Brain Imaging Behav; 2021 Jun; 15(3):1364-1373. PubMed ID: 32710338
[TBL] [Abstract][Full Text] [Related]
28. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
29. Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy.
McDonald BC; Van Dyk K; Deardorff RL; Bailey JN; Zhai W; Carroll JE; Root JC; Ahles TA; Mandelblatt JS; Saykin AJ
Breast Cancer Res Treat; 2022 Jul; 194(1):113-126. PubMed ID: 35476252
[TBL] [Abstract][Full Text] [Related]
30. Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.
McDonald BC; Conroy SK; Ahles TA; West JD; Saykin AJ
J Clin Oncol; 2012 Jul; 30(20):2500-8. PubMed ID: 22665542
[TBL] [Abstract][Full Text] [Related]
31. Childhood leukemia survivors exhibit deficiencies in sensory and cognitive processes, as reflected by event-related brain potentials after completion of curative chemotherapy: A preliminary investigation.
Brace KM; Lee WW; Cole PD; Sussman ES
J Clin Exp Neuropsychol; 2019 Oct; 41(8):814-831. PubMed ID: 31156064
[No Abstract] [Full Text] [Related]
32. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.
de Ruiter MB; Reneman L; Boogerd W; Veltman DJ; van Dam FS; Nederveen AJ; Boven E; Schagen SB
Hum Brain Mapp; 2011 Aug; 32(8):1206-19. PubMed ID: 20669165
[TBL] [Abstract][Full Text] [Related]
33. Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument.
Von Ah D; Tallman EF
J Pain Symptom Manage; 2015 Apr; 49(4):697-706. PubMed ID: 25240787
[TBL] [Abstract][Full Text] [Related]
34. Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors.
Bruno J; Hosseini SM; Kesler S
Neurobiol Dis; 2012 Dec; 48(3):329-38. PubMed ID: 22820143
[TBL] [Abstract][Full Text] [Related]
35. Brain structure, working memory and response inhibition in childhood leukemia survivors.
van der Plas E; Schachar RJ; Hitzler J; Crosbie J; Guger SL; Spiegler BJ; Ito S; Nieman BJ
Brain Behav; 2017 Feb; 7(2):e00621. PubMed ID: 28239531
[TBL] [Abstract][Full Text] [Related]
36. Investigation of chemotherapy-induced brain structural alterations in breast cancer patients with generalized q-sampling MRI and graph theoretical analysis.
Li TY; Chen VC; Yeh DC; Huang SL; Chen CN; Chai JW; Chen CC; Weng JC
BMC Cancer; 2018 Dec; 18(1):1211. PubMed ID: 30514266
[TBL] [Abstract][Full Text] [Related]
37. Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
Ganz PA; Bower JE; Kwan L; Castellon SA; Silverman DH; Geist C; Breen EC; Irwin MR; Cole SW
Brain Behav Immun; 2013 Mar; 30 Suppl(Suppl):S99-108. PubMed ID: 22884417
[TBL] [Abstract][Full Text] [Related]
38. Cognitive impairment after chemotherapy related to atypical network architecture for executive control.
Piccirillo JF; Hardin FM; Nicklaus J; Kallogjeri D; Wilson M; Ma CX; Coalson RS; Shimony J; Schlaggar BL
Oncology; 2015; 88(6):360-8. PubMed ID: 25678046
[TBL] [Abstract][Full Text] [Related]
39. Effects of aripiprazole and haloperidol on neural activation during the n-back in healthy individuals: A functional MRI study.
Goozee R; Reinders AATS; Handley R; Marques T; Taylor H; O'Daly O; McQueen G; Hubbard K; Mondelli V; Pariante C; Dazzan P
Schizophr Res; 2016 Jun; 173(3):174-181. PubMed ID: 25778615
[TBL] [Abstract][Full Text] [Related]
40. Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study.
McDonald BC; Conroy SK; Ahles TA; West JD; Saykin AJ
Breast Cancer Res Treat; 2010 Oct; 123(3):819-28. PubMed ID: 20690040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
